 "RPG Life Sciences hits record high on promoter buying")
Shares of RPG Life Sciences have rallied 6% to Rs 156 on the National Stock Exchange after the promoter of the pharmaceutical company buying shares through open market.
The stock opened at Rs 150 and touched a record high of Rs 160 on the NSE. Till 1004 hours, a combined 379,698 shares changed hands against an average sub 500,000 shares that were traded daily in past two weeks on the NSE and BSE.
In past two-weeks, the stock rallied 49% from Rs 105 after Harsh Vardhan Goneka, trustee of Nucleus Life Trust, bought 277,165 equity shares representing 1.7% of total equity of RPG Life Sciences through open market. The CNX Nifty dipped 3.3% during the same period.
On March 26, Nucleus Life Trust had purchased 83,376 shares of RPG Life Sciences at an average price of Rs 142.47 per share on the NSE, the bulk deal data shows.
Earlier, between March 16 and March 18, Nucleus Life Trust acquired 189,789 shares of the company through BSE and NSE, RPG Life Sciences said in a regulatory filing.
As of December 2014, Harsh Vardhan Goneka and along with other promoters held 61.83% stake in RPG Life Sciences, the shareholding pattern data shows.
The stock opened at Rs 150 and touched a record high of Rs 160 on the NSE. Till 1004 hours, a combined 379,698 shares changed hands against an average sub 500,000 shares that were traded daily in past two weeks on the NSE and BSE.
In past two-weeks, the stock rallied 49% from Rs 105 after Harsh Vardhan Goneka, trustee of Nucleus Life Trust, bought 277,165 equity shares representing 1.7% of total equity of RPG Life Sciences through open market. The CNX Nifty dipped 3.3% during the same period.
On March 26, Nucleus Life Trust had purchased 83,376 shares of RPG Life Sciences at an average price of Rs 142.47 per share on the NSE, the bulk deal data shows.
Earlier, between March 16 and March 18, Nucleus Life Trust acquired 189,789 shares of the company through BSE and NSE, RPG Life Sciences said in a regulatory filing.
As of December 2014, Harsh Vardhan Goneka and along with other promoters held 61.83% stake in RPG Life Sciences, the shareholding pattern data shows.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%